[HTML][HTML] Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19

H Sidky, KA Hansen, AT Girvin, N Hotaling… - Computational and …, 2024 - Elsevier
Background Post-acute sequelae of COVID-19 (PASC) produce significant morbidity,
prompting evaluation of interventions that might lower risk. Selective serotonin reuptake …

[HTML][HTML] Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19

H Sidky, KA Hansen, AT Girvin, N Hotaling… - Computational and …, 2024 - csbj.org
Background Post-acute sequelae of COVID-19 (PASC) produce significant morbidity,
prompting evaluation of interventions that might lower risk. Selective serotonin reuptake …

[HTML][HTML] Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19

H Sidky, DK Sahner, AT Girvin, N Hotaling, SG Michael… - 2022 - europepmc.org
Objectives The main objective was to evaluate whether SSRIs with agonist activity at the
sigma-1 receptor lower the risk of PASC, since agonism at this receptor may serve as a …

Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19

H Sidky, DK Sahner, AT Girvin, N Hotaling, SG Michael… - medRxiv, 2022 - medrxiv.org
Importance Post-acute sequelae of COVID-19 (PASC) produce significant morbidity,
prompting evaluation of interventions that might lower risk. Selective serotonin reuptake …

Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19

H Sidky, KA Hansen, AT Girvin… - Computational …, 2024 - repository.escholarship.umassmed …
Background: Post-acute sequelae of COVID-19 (PASC) produce significant morbidity,
prompting evaluation of interventions that might lower risk. Selective serotonin reuptake …

Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19

H Sidky, DK Sahner, AT Girvin… - … : the preprint server …, 2023 - pubmed.ncbi.nlm.nih.gov
Importance Post-acute sequelae of COVID-19 (PASC) produce significant morbidity,
prompting evaluation of interventions that might lower risk. Selective serotonin reuptake …

[PDF][PDF] Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19

H Sidky, KA Hansen, AT Girvin… - Computational and …, 2024 - scienceopen.com
Background: Post-acute sequelae of COVID-19 (PASC) produce significant morbidity,
prompting evaluation of interventions that might lower risk. Selective serotonin reuptake …

[HTML][HTML] Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19

H Sidky, KA Hansen, AT Girvin, N Hotaling… - Computational and …, 2024 - ncbi.nlm.nih.gov
Background Post-acute sequelae of COVID-19 (PASC) produce significant morbidity,
prompting evaluation of interventions that might lower risk. Selective serotonin reuptake …

[HTML][HTML] Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19

H Sidky, DK Sahner, AT Girvin, N Hotaling, SG Michael… - medRxiv, 2022 - medrxiv.org
Importance Post-acute sequelae of COVID-19 (PASC) produce significant morbidity,
prompting evaluation of interventions that might lower risk. Selective serotonin reuptake …

[HTML][HTML] Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19

H Sidky, DK Sahner, AT Girvin, N Hotaling, SG Michael… - medRxiv - ncbi.nlm.nih.gov
Objectives: The main objective was to evaluate whether SSRIs with agonist activity at the
sigma-1 receptor lower the risk of PASC, since agonism at this receptor may serve as a …